| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 16.031 | 7.145 | 6.281 | 5.291 | 4.882 | 4.417 | 5.837 | 4.841 | 5.106 | 2.998 |
| Total Income - EUR | 16.034 | 7.145 | 6.281 | 5.291 | 4.882 | 4.417 | 5.837 | 4.841 | 5.107 | 2.999 |
| Total Expenses - EUR | 7.646 | 5.403 | 6.484 | 5.040 | 2.614 | 2.812 | 3.704 | 5.158 | 3.456 | 3.966 |
| Gross Profit/Loss - EUR | 8.388 | 1.742 | -203 | 251 | 2.268 | 1.605 | 2.132 | -317 | 1.651 | -966 |
| Net Profit/Loss - EUR | 7.907 | 1.527 | -391 | 92 | 2.122 | 1.476 | 1.957 | -459 | 1.201 | -987 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Isodia M.d. Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.859 | 2.145 | 1.686 | 834 | 416 | 680 | 3.615 | 2.869 | 2.817 | 2.651 |
| Current Assets | 15.145 | 9.792 | 5.371 | 10.592 | 14.028 | 9.863 | 8.423 | 3.329 | 6.472 | 3.765 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 12.461 | 8.973 | 3.034 | 226 | 1.786 | 2.583 | 1.967 | 2.023 | 3.303 | 1.486 |
| Cash | 2.684 | 819 | 2.336 | 10.366 | 12.242 | 7.281 | 6.456 | 1.306 | 3.170 | 2.279 |
| Shareholders Funds | 7.961 | 1.581 | 1.163 | 1.233 | 3.331 | 4.745 | 6.597 | 2.065 | 3.260 | 2.255 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 9.043 | 10.363 | 5.894 | 10.217 | 11.112 | 5.799 | 5.446 | 4.132 | 6.029 | 4.160 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4617 - 4617" | |||||||||
| CAEN Financial Year |
6311
|
|||||||||
Comments - Isodia M.d. Srl